43 results
8-K
EX-99.1
CCCC
C4 Therapeutics Inc
8 May 24
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:07am
recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
the target protein is poly- ubiquitinated, it is released by the E3 ligase and is then quickly recognized by a proteasome, which is the cell’s recycling
8-K
EX-99.1
CCCC
C4 Therapeutics Inc
4 Mar 24
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
7:05am
. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering
8-K
EX-99.1
xurkyg0imz qg
22 Feb 24
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:15am
8-K
EX-99.1
khun6csr9l2
11 Jan 24
Regulation FD Disclosure
7:05am
8-K
EX-99.1
hsg8j6
9 Jan 24
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
4:06pm
8-K
EX-99.2
5k2vy7ur6el630t
12 Dec 23
Regulation FD Disclosure
4:28pm
8-K
EX-99.1
bbl2so6 gs9q08
12 Dec 23
Entry into a Material Definitive Agreement
7:15am
8-K
EX-99.1
myn9n2
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
EX-99.1
5kd82f qc
1 Nov 23
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
7:18am
8-K
EX-99.1
j4ov 63n7uzie4x
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm
8-K
EX-99.1
plx4ui169fu252k0
8 Aug 23
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
7:09am
8-K
EX-99.1
on0iygnygw8ln
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
8-K
EX-99.1
h4dd zho1vs1u6
30 May 23
Entry into a Material Definitive Agreement
7:30am